Curcumin Bioavailability in Glioblastoma Patients

Measurement of Intratumoral Concentration of the Nontoxic Natural Compound Curcumin in Glioblastoma Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01712542

Enrollment

Registered

2012-10-23

Start date

2012-10-31

Completion date

2013-05-31

Last updated

2013-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient Harboring Glioblastoma That Will Undergo Surgery

Brief summary

Measuring the bioavailability of orally administered curcumin in the tumors of glioblastoma patients.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients harboring Glioblastoma * Patient will undergo surgery

Exclusion criteria

* BMI \> 30 * Liver and Kidney Function so compromised that medication is prescribed

Design outcomes

Primary

Measure	Time frame	Description
Concentration of Curcumin in Glioblastoma	At Tumor resection	At the time of surgery

Countries

Germany

Outcome results